Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

NCT06138561 · clinicaltrials.gov ↗

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Metastatic Bladder Cancer
Unresectable Bladder Carcinoma
Urothelial Carcinoma

Interventions

BEHAVIORAL: Geriatric-8 Survey
BEHAVIORAL: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Bladder Symptom Index-18 (FBISI-18)
BEHAVIORAL: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®)

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]